POPULARITY
20 episodes with hormonal therapy
9 episodes with hormonal therapy
6 episodes with hormonal therapy
2 episodes with hormonal therapy
2 episodes with hormonal therapy
2 episodes with hormonal therapy
2 episodes with hormonal therapy
Parents often want to talk to their kids about puberty and periods, but many don't know where to start. In this episode, I'm joined by pediatric and adolescent gynecologist Dr. Charis Chambers to talk about how we can change the way families approach these conversations. From stigma and misinformation to the fear of saying the wrong thing, we break down why avoiding these discussions can leave kids confused, scared, or learning from the wrong sources. We discuss how to introduce puberty and body changes in age-appropriate ways, why boys should be included in these conversations, and how parents can shift from one awkward “talk” to an ongoing dialog that builds trust. Dr. Chambers also explains the science behind periods, addresses common misconceptions about hormonal therapy, and shares powerful stories from her clinical experience that highlight why this education matters for a child's long-term relationship with their body and health. In this episode we discuss: ✔️ Why many kids feel scared when their first period starts ✔️ How to start puberty conversations earlier and more naturally ✔️ Why boys should learn about periods too ✔️ The difference between privacy and secrecy when talking about bodies ✔️ How stigma around periods gets passed down through generations ✔️ Why hormonal therapy is often misunderstood ✔️ How open conversations build trust between parents and kids To connect with Dr. Charis Chambers follow her on Instagram @theperioddoctor, check out all her resources at https://theperioddoctor.com and buy her new book: https://www.amazon.com/Period-Puberty-Parenting-Revolution-Conversation/dp/1464233802?utm_source=ig&utm_medium=social&utm_content=link_in_bio&fbclid=PAZXh0bgNhZW0CMTEAc3J0YwZhcHBfaWQMMjU2MjgxMDQwNTU4AAGn1W3WTCmZ7O5OBTdANGfFNf3Qt3tBhR3ysalxz3dPwNe50CLKDpwfK9vbRiY_aem_POnDC67y5COyXEaA3xsKVQ 00:00 Why Puberty and Period Talks Matter 02:16 Meet Dr. Charis Chambers and Her New Book 04:01 Why She Wrote The Puberty and Period Parenting Revolution 06:17 Why Kids Need to Learn About Bodies From Parents First 08:42 Is There Such a Thing as Talking Too Early About Puberty? 10:54 Why Boys Need to Be Part of Period Conversations Too 12:35 Privacy vs Secrecy, How Parents Can Normalize Periods 14:00 How Media and Shame Shape Period Stigma 18:40 Why This Needs to Be an Ongoing Conversation, Not One Talk 22:31 How to Explain Anatomy Without Making It Awkward 28:15 What Happens When Kids Are Left in the Dark About Periods 33:54 Hormonal Therapy vs Birth Control, What Parents Should Know 41:29 How to Build Trust When Parents Feel Nervous or Behind 45:05 What Dr. Charis Hopes This Book Changes for Families Our podcasts are also now on YouTube. If you prefer a video podcast with closed captioning, check us out there and subscribe to PedsDocTalk. Get trusted pediatric advice, relatable parenting insights, and evidence-based tips delivered straight to your inbox—join thousands of parents who rely on the PDT newsletter to stay informed, supported, and confident. Join the newsletter! And don't forget to follow @pedsdoctalkpodcast on Instagram—our new space just for parents looking for real talk and real support. We love the sponsors that make this show possible! You can always find all the special deals and codes for all our current sponsors on the PedsDocTalk Podcast Sponsorships page of the website. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Parents often want to talk to their kids about puberty and periods, but many don't know where to start. In this episode, I'm joined by pediatric and adolescent gynecologist Dr. Charis Chambers to talk about how we can change the way families approach these conversations. From stigma and misinformation to the fear of saying the wrong thing, we break down why avoiding these discussions can leave kids confused, scared, or learning from the wrong sources. We discuss how to introduce puberty and body changes in age-appropriate ways, why boys should be included in these conversations, and how parents can shift from one awkward “talk” to an ongoing dialog that builds trust. Dr. Chambers also explains the science behind periods, addresses common misconceptions about hormonal therapy, and shares powerful stories from her clinical experience that highlight why this education matters for a child's long-term relationship with their body and health. In this episode we discuss: ✔️ Why many kids feel scared when their first period starts ✔️ How to start puberty conversations earlier and more naturally ✔️ Why boys should learn about periods too ✔️ The difference between privacy and secrecy when talking about bodies ✔️ How stigma around periods gets passed down through generations ✔️ Why hormonal therapy is often misunderstood ✔️ How open conversations build trust between parents and kids To connect with Dr. Charis Chambers follow her on Instagram @theperioddoctor, check out all her resources at https://theperioddoctor.com and buy her new book: https://www.amazon.com/Period-Puberty-Parenting-Revolution-Conversation/dp/1464233802?utm_source=ig&utm_medium=social&utm_content=link_in_bio&fbclid=PAZXh0bgNhZW0CMTEAc3J0YwZhcHBfaWQMMjU2MjgxMDQwNTU4AAGn1W3WTCmZ7O5OBTdANGfFNf3Qt3tBhR3ysalxz3dPwNe50CLKDpwfK9vbRiY_aem_POnDC67y5COyXEaA3xsKVQ 00:00 Why Puberty and Period Talks Matter 02:16 Meet Dr. Charis Chambers and Her New Book 04:01 Why She Wrote The Puberty and Period Parenting Revolution 06:17 Why Kids Need to Learn About Bodies From Parents First 08:42 Is There Such a Thing as Talking Too Early About Puberty? 10:54 Why Boys Need to Be Part of Period Conversations Too 12:35 Privacy vs Secrecy, How Parents Can Normalize Periods 14:00 How Media and Shame Shape Period Stigma 18:40 Why This Needs to Be an Ongoing Conversation, Not One Talk 22:31 How to Explain Anatomy Without Making It Awkward 28:15 What Happens When Kids Are Left in the Dark About Periods 33:54 Hormonal Therapy vs Birth Control, What Parents Should Know 41:29 How to Build Trust When Parents Feel Nervous or Behind 45:05 What Dr. Charis Hopes This Book Changes for Families Our podcasts are also now on YouTube. If you prefer a video podcast with closed captioning, check us out there and subscribe to PedsDocTalk. Get trusted pediatric advice, relatable parenting insights, and evidence-based tips delivered straight to your inbox—join thousands of parents who rely on the PDT newsletter to stay informed, supported, and confident. Join the newsletter! And don't forget to follow @pedsdoctalkpodcast on Instagram—our new space just for parents looking for real talk and real support. We love the sponsors that make this show possible! You can always find all the special deals and codes for all our current sponsors on the PedsDocTalk Podcast Sponsorships page of the website. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer — Andrew J Armstrong, MD, ScM CME information and select publications
Featuring perspectives from Dr Andrew J Armstrong and Dr Scott T Tagawa, including the following topics: Introduction: Evolution of the Prostate Cancer Model; Prostate Cancer Working Group 4 (PCWG4) (0:00) Hormonal Therapy (5:48) Chemotherapy (Docetaxel) (26:38) PARP Inhibition (29:49) Radioligand Therapy (36:56) New Agents (43:37) CME information and select publications
A Podcast from Obstetrics & Gynecology highlighting the latest research and practice updates in the field. This episode features an interview with Dr. Intira Sriprasert, author of "Elimination of the Black Box Warning on Menopausal Hormone Therapy."
Featuring perspectives from Dr Emmanuel S Antonarakis and Dr Matthew R Smith, including the following topics: Introduction (0:00) Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer — Dr Smith (0:55) Available and Emerging Therapeutic Approaches for Metastatic Castration-Resistant Prostate Cancer — Dr Antonarakis (26:37) CE information and select publications
Antoni J. Duleba, M.D. outlines the broad scope of reproductive endocrinology and infertility, emphasizing care across a woman's lifespan—from adolescence through menopause. He explains common endocrine conditions like polycystic ovary syndrome (PCOS), endometriosis, and menstrual disorders, all of which can affect fertility and overall health. Duleba highlights advances in fertility preservation, especially for patients undergoing cancer treatment, and notes the rising need for such services as more women delay childbearing. He also addresses efforts to improve hormonal therapies, IVF outcomes, and treatments that target inflammation and the microbiome. In addition to medical innovation, he points to social and financial barriers that continue to limit access to reproductive care. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40672]
Antoni J. Duleba, M.D. outlines the broad scope of reproductive endocrinology and infertility, emphasizing care across a woman's lifespan—from adolescence through menopause. He explains common endocrine conditions like polycystic ovary syndrome (PCOS), endometriosis, and menstrual disorders, all of which can affect fertility and overall health. Duleba highlights advances in fertility preservation, especially for patients undergoing cancer treatment, and notes the rising need for such services as more women delay childbearing. He also addresses efforts to improve hormonal therapies, IVF outcomes, and treatments that target inflammation and the microbiome. In addition to medical innovation, he points to social and financial barriers that continue to limit access to reproductive care. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40672]
Antoni J. Duleba, M.D. outlines the broad scope of reproductive endocrinology and infertility, emphasizing care across a woman's lifespan—from adolescence through menopause. He explains common endocrine conditions like polycystic ovary syndrome (PCOS), endometriosis, and menstrual disorders, all of which can affect fertility and overall health. Duleba highlights advances in fertility preservation, especially for patients undergoing cancer treatment, and notes the rising need for such services as more women delay childbearing. He also addresses efforts to improve hormonal therapies, IVF outcomes, and treatments that target inflammation and the microbiome. In addition to medical innovation, he points to social and financial barriers that continue to limit access to reproductive care. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40672]
Antoni J. Duleba, M.D. outlines the broad scope of reproductive endocrinology and infertility, emphasizing care across a woman's lifespan—from adolescence through menopause. He explains common endocrine conditions like polycystic ovary syndrome (PCOS), endometriosis, and menstrual disorders, all of which can affect fertility and overall health. Duleba highlights advances in fertility preservation, especially for patients undergoing cancer treatment, and notes the rising need for such services as more women delay childbearing. He also addresses efforts to improve hormonal therapies, IVF outcomes, and treatments that target inflammation and the microbiome. In addition to medical innovation, he points to social and financial barriers that continue to limit access to reproductive care. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40672]
Antoni J. Duleba, M.D. outlines the broad scope of reproductive endocrinology and infertility, emphasizing care across a woman's lifespan—from adolescence through menopause. He explains common endocrine conditions like polycystic ovary syndrome (PCOS), endometriosis, and menstrual disorders, all of which can affect fertility and overall health. Duleba highlights advances in fertility preservation, especially for patients undergoing cancer treatment, and notes the rising need for such services as more women delay childbearing. He also addresses efforts to improve hormonal therapies, IVF outcomes, and treatments that target inflammation and the microbiome. In addition to medical innovation, he points to social and financial barriers that continue to limit access to reproductive care. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40672]
Antoni J. Duleba, M.D. outlines the broad scope of reproductive endocrinology and infertility, emphasizing care across a woman's lifespan—from adolescence through menopause. He explains common endocrine conditions like polycystic ovary syndrome (PCOS), endometriosis, and menstrual disorders, all of which can affect fertility and overall health. Duleba highlights advances in fertility preservation, especially for patients undergoing cancer treatment, and notes the rising need for such services as more women delay childbearing. He also addresses efforts to improve hormonal therapies, IVF outcomes, and treatments that target inflammation and the microbiome. In addition to medical innovation, he points to social and financial barriers that continue to limit access to reproductive care. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40672]
Antoni J. Duleba, M.D. outlines the broad scope of reproductive endocrinology and infertility, emphasizing care across a woman's lifespan—from adolescence through menopause. He explains common endocrine conditions like polycystic ovary syndrome (PCOS), endometriosis, and menstrual disorders, all of which can affect fertility and overall health. Duleba highlights advances in fertility preservation, especially for patients undergoing cancer treatment, and notes the rising need for such services as more women delay childbearing. He also addresses efforts to improve hormonal therapies, IVF outcomes, and treatments that target inflammation and the microbiome. In addition to medical innovation, he points to social and financial barriers that continue to limit access to reproductive care. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 40672]
Short term weight loss sounds great BUT it's not all fat – it's muscle! Muscle will be much harder to regain as we age because of anabolic resistance.. Clothes might feel loose and you get weight loss compliments. But short term weight loss is just giving a “false positive” honeymoon period. This might mean you divorced muscle, the love of your life. 1. Muscle Mass Loss (Sarcopenia) Protein Deficiency Protein is essential for building and maintaining muscle tissue. Insufficient protein intake exacerbates muscle atrophy and increases the risk of falls and injuries. Excessive Cardio Prolonged cardio can lead to a breakdown of muscle tissue for energy, particularly if glycogen stores are depleted. This can worsen age-related muscle loss and counteract maintaining strength and function. 2. Bone Health (Osteoporosis) Protein Deficiency Protein is needed for bone health and bone density. Inadequate protein intake, especially after menopause, increases the risk of osteoporosis and fractures. Osteoporosis Risks After menopause, risk of osteoporosis increases due to declining estrogen levels and can weaken bones prone to fracture. Sarcopenia and Osteoporosis Link Having both increases the risk of falls and fractures. Poor nutrition leads to sarcopenic obesity and increases the risk of osteoporosis. 3. Other Negative Effects Reduced Physical Function Since inadequate protein leads to muscle loss, this reduces strength, impaired balance, and decreased ability to perform daily activities. Slow-Healing Injuries Protein repairs tissues. Deficiency can slow wound healing and recovery from injuries. Weakened Immune Function Amino acids from protein build antibodies and maintain a healthy immune system. Low protein intake can lead to frequent illnesses and infections. Potential Cardiac Issues (Excessive Cardio) Associated with potential adverse cardiac effects, such as myocardial fibrosis and an increased risk of atrial fibrillation, in some individuals. Musculoskeletal Injuries (Excessive Cardio) Increases the risk of musculoskeletal issues like osteoarthritis and stress fractures. What Can You Do Instead of A Short Term Weight Loss Recommendations: Prioritize protein intake with 30 grams each meal. Balance cardio and strength training to build and maintain muscle mass. Listen to your body and avoid pushing yourself too hard or engaging in prolonged, strenuous exercise if it causes excessive fatigue or pain. References: Chucherd O, Vallibhakara O, Vallibhakara SA, Sophonsritsuk A, Chattrakulchai K, Anantaburarana M. Association of Sarcopenic Obesity and Osteoporosis in Postmenopausal Women: Risk Factors and Protective Effects of Hormonal Therapy and Nutritional Status. Arch Osteoporos. 2025 Jun 26;20(1):83. doi: 10.1007/s11657-025-01573-w. PMID: 40569474; PMCID: PMC12202630. Filip Vuletić, Berte Bøe, Considerations in the Aging Female Athlete, Operative Techniques in Sports Medicine, Volume 32, Issue 2, 2024, 151091, ISSN 1060-1872, https://doi.org/10.1016/j.otsm.2024.151091. Other Episodes You Might Like: Previous Episode - Simple Ways to Know if You're Following Protein Rules in Menopause Next Episode - What to Do When Joints Hurt, Ache or Need Replaced? A Doctor Viewpoint More Like This - Protein for Menopause Hormone Support Resources: Join the Flipping50 Membership for evidence-based workout programs. Short & Easy Exercise videos in this 5 Day Flip Challenge. Get the Flipping 50 Protein & Fiber supplements for women over 50 to support muscle health, enhance recovery, and meet daily nutritional needs.
Menopausal hormonal therapy should not be a blanket recommendation for everyone going through menopauseWeight management in women is influenced by hormonal changes throughout life stages.Retrospective analyses can provide insights but have limitations.The wellness industry often oversimplifies complex medical issues.Hormonal replacement therapy may have subtle benefits for weight management.Confounding factors like SSRIs can complicate weight loss efforts.A holistic approach is essential for managing women's health during menopause.Education and awareness are crucial for women navigating menopause.Future research should focus on randomized controlled trials for better clarity.Understanding individual patient experiences is key to effective treatment.Click here to see her studyClick here to follow Dr. Tchang on XClick here to join Dr. Spencer's clinic Vineyard
At the 2025 American Society of Clinical Oncology Annual Meeting, Hope Rugo, MD, chaired a session on managing the side effects of new breast cancer treatments and also presented information on how to manage the side effects of hormonal therapy medicines, which are used to treat hormone receptor-positive breast cancer. Listen to the episode to hear Dr. Rugo explain: ways to manage the side effects of tamoxifen and the aromatase inhibitors why talking to your doctor about side is crucial to managing them her advice for people who are having side effects from hormonal therapy medicines
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer (PC) — Professor Karim Fizazi, MD, PhD CME information and select publications
Featuring perspectives from Dr Rahul Aggarwal and Dr William K Oh, including the following topics: Hormonal Therapy for Patients with Prostate Cancer — Dr Oh (0:00) Other Available and Emerging Therapeutic Approaches — Dr Aggarwal (27:14) CME information and select publications
Dr. Amy Novatt delves into the complex and often misunderstood realm of menopause hormonal therapy, previously known as Hormone Replacement Therapy (HRT). Dr. Novatt is joined by Dr. Liz Lyster, an OB-GYN and midlife health expert, to discuss the history, controversies, and current understanding surrounding hormone therapy. The conversation includes an in-depth look at the impact of the landmark 2002 Women's Health Initiative (WHI) study, which drastically changed the public perception and medical approach to HRT, and moves on to explore bio-identical hormones, safer methods of administration, and the importance of individualized treatment plans. Dr. Lyster provides expert insights into the benefits of hormone therapy, including its role in alleviating menopausal symptoms, improving bone density, and potentially lowering the risks of heart disease, dementia, and certain cancers. Both hosts emphasize the significance of personalized medical advice and the need to consider each woman's unique health profile and family history. The episode also covers practical advice on when to start hormone therapy, the importance of a baseline bone density scan at age 50, and the often misunderstood concept of 'estrogen dominance.' They encourage listeners to proactively engage with their healthcare providers and to consider hormone therapy as a viable option for improving quality of life during the menopausal transition. On a more personal note, Dr. Lyster shares her recent experiences with loss and grief. This segment underscores the broader theme of reinvention and resilience during midlife, touching on how managing one's health can help navigate the emotional and physical changes that accompany this stage of life. Questions of comments? Call 845-307-7446 or email comments@radiofreerhinecliff.org Produced by Jennifer Hammoud and Matty Rosenberg @ Radio Free Rhiniecliff
Editor’s Choice: The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study Editorial: Hormonal maintenance therapy for advance low grade serous ovarian carcinoma appears to be of benefit – That's a relief!
New research suggests that estrogen plays a role in allowing hormone receptor-negative breast cancer to grow. This is because estrogen limits the ability of the immune system to attack cancer cells; it also makes immunotherapy medicines, like Keytruda (chemical name: pembrolizumab), less effective. Dr. Donald McDonnell, senior author of the study, explains the results and how they might make a difference for people with breast cancer. Listen to the episode to hear Dr. McDonnell explain: what eosinophils are and how he started studying them in connection with breast cancer how estrogen in the body affects the immune system how a hormonal therapy medicine, like tamoxifen, can make an immunotherapy medicine, like Keytruda, more effective
Apply to the Cancer Freedom Program here: www.cancerfreedomprogram.com Of course you know that taking hormonal therapy will help prevent your cancer from coming back. But you also know the side effects are SCARY! Life changing. You don't feel like yourself. Now - you want to quit. What should you do? In this episode I'm showing you exactly what you need to know if you want to quit taking hormonal therapy for breast cancer. Whatever you decide, you have my support. Let's get you all the right information first! So let me show you how it's done. Join the Cancer Freedom Program Click HERE www.cancerfreedomprogram.com #cancersurvivor #cancerfighter #breastcancer #cancerrecovery #cancernutrition #mastectomy #tamoxifen #anastrozole #letrozole #signatara PS - Whenever you are ready, here the 2 best ways I can help you - 1) “Your A-Z Guide to Staying Cancer Free” **FREE** Click here: https://bit.ly/azcancerfree 2)Join the Cancer Freedom Program Click HERE: www.cancerfreedomprogram.com ***Let's Connect: Website: www.cancerfreedomprogram.com Instagram: https://www.instagram.com/dramymorris/ YouTube: https://www.youtube.com/channel/UCUt9... Facebook: https://www.facebook.com/dramycancer/
In the THRIVE trial, sexual side effects caused by hormonal therapy led to lower mental quality of life in both Black and white women, but caused lower physical quality of life only in Black women. Sexual side effects were also linked to Black women being less likely to take hormonal therapy as prescribed, but not white women. Dr. Janeane Anderson, who analyzed the THRIVE data, explains why it's so important for anyone who's received breast cancer treatment to talk to their doctors about any and all sexual health problems they're having. Listen to the episode to hear Dr. Anderson discuss: Why sexual health is one of the most significant unmet needs among breast cancer survivors of breast cancer, regardless of race. The most common sexual health side effects of hormonal therapy. Her advice to women who aren't comfortable talking about sex and sexuality with their oncologists.
Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O'Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander, including the following topics: Introduction (0:00) Role of Hormonal Therapy in Prostate Cancer Management — Dr M Smith (10:54) Other Available and Emerging Therapeutic Approaches — Dr Srinivas (37:03) CME information and select publications
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published updated meta-analysis on impact of gender-affirming hormonal therapy on cardiovascular risk factors in transgender health.
In a episode of *Your Health Matters*, host Karl Sterling, co-host Elizabeth Bruce, and guest expert Dr. Sherie Viencek explored the connection between hormones and brain health, especially in relation to aging and cognitive conditions like Alzheimer's disease. Dr. Viencek, with over 30 years of experience in integrative health, shared insights into how hormonal changes impact brain function and overall well-being. Hormonal Therapy and Brain Health Dr. Viencek explained the optimal timing for starting hormone replacement therapy (HRT), emphasizing that starting at 55 or older significantly reduces biological aging. Research from Stanford shows that continued HRT use enhances metabolic activity and brain function. She pointed out that the old recommendation to stop HRT at 60-65 is now considered outdated. Recent guidelines suggest discontinuing HRT based on personal health needs rather than age. Key points: - HRT at 55 or older: Reduces biological aging and supports brain function. - Ongoing HRT: Benefits metabolism and cognition. - New guidelines: Routine discontinuation at 60-65 is no longer necessary. Thyroid Health Dr. Viencek noted that around 20 million Americans have hypothyroidism, with many undiagnosed due to inadequate thyroid testing. She stressed the importance of comprehensive thyroid panels, including antibody testing, as low T3 hormone levels are linked to depression and cognitive issues. This highlights the importance of thorough thyroid evaluations, especially for patients with depression. Key points: - Hypothyroidism prevalence: 20 million Americans, with many undiagnosed. - T3 hormone: Critical for brain function, low levels linked to depression. - Comprehensive thyroid panels: Necessary for accurate diagnosis. Lifestyle Factors for Brain Health Dr. Viencek shared findings from the UK Biobank that regular napping is associated with larger brain volume, suggesting potential protection against cognitive decline. Additionally, she discussed a study showing that inhaling pleasant aromas during sleep can significantly improve memory, revealing the impact of sensory experiences on cognitive health. Key points: - Napping: Linked to larger brain volumes and potential cognitive protection. - Pleasant aromas during sleep: Can enhance memory. Meditation and Cognitive Function Dr. Viencek recommended a daily 12-minute meditation practice called *Chi Pre Yoga*, which has been shown to reduce the risk of Alzheimer's, improve memory, sleep quality, and boost immune function. Meditation, she emphasized, is a simple yet powerful tool for brain health. Key points: - Chi Pre Yoga: A daily 12-minute meditation that helps reduce Alzheimer's risk. - Benefits: Improves memory, sleep, and immunity. Conclusion and Call to Action Karl Sterling encouraged listeners to take proactive steps in their health, particularly by seeking comprehensive hormonal and thyroid evaluations. Dr. Viencek emphasized the importance of understanding how hormonal balance impacts brain health and urged listeners to address these issues early for better cognitive function as they age. Listeners were reminded to consult healthcare providers for personalized advice and to stay informed through Dr. Viencek's resources at Sage Functional Health, which includes upcoming webinars on hormone testing and management. This episode offered valuable insights into how hormones, lifestyle choices, and practices like meditation can significantly influence brain health, providing actionable steps to maintain cognitive function and well-being as we age. Be sure to visit http://www/sagefunctionalhealth.com
In this episode of Stellar Cycles, we're diving into endometriosis—a common but often overlooked condition affecting women's reproductive health. As someone with hands-on experience in women's health, I'll explain what endometriosis is, the symptoms you should be aware of, how it's diagnosed, and its potential causes. We'll explore key topics like endometriosis symptoms, diagnostic tests, and treatment options, including hormonal therapy and surgical interventions. I'll also share tips on managing chronic pain, understanding the condition's impact on fertility, and improving your overall quality of life. Whether you're newly diagnosed or looking for more information, this episode aims to simplify the complexities of endometriosis management and help you feel more informed. Remember, this is just an overview based on my experience—always consult your doctor for personalized advice. Tune in to get the facts on endometriosis, its challenges, and how to manage it in your daily life. Don't forget to like, comment, and subscribe for more tips on women's health, wellness, and reproductive health!Download our FREE phasic foods grocery guide here! Stellar Cycles Instagram @stellarcyclespod Use code STELLAR10 for 10% off BioOptimizers magnesium supplementsListen on SpotifyListen on Apple Podcasts
In this episode, Yvonne Gilleece, MB BCh, BAO, FRCP, uses a case study to illustrate why giving people space and time to engage in HIV care on their terms is key to overcoming potential shame and stigma.She discusses how people can be very vulnerable when engaging in HIV care, and trauma-informed care can help address these vulnerabilities in a safe, respectful way. Listen as she gives her perspectives on:Trauma-informed careOvercoming stigma and shameStaying in care Presenter:Yvonne Gilleece, MB BCh, BAO, FRCPHonorary Clinical Professor and Consultant in HIV Medicine & Sexual HealthBrighton & Sussex Medical School and University Hospitals Sussex NHS Foundation TrustChair of the British HIV AssociationLead for HIV & WomenLead for HIV & HepatitisBrighton, United KingdomContent based on an online CME program supported by an educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3xicSeFGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Ever wondered if hormones could be the secret culprit behind relationship ups and downs? In this revealing episode of The Dr. Terri Show, my husband Dan DeNeui and I dive deep into the surprising ways hormones can affect everything from intimacy and communication to mood swings and stress levels. We share our own personal experiences, insights, and advice on how to navigate hormonal changes, improve communication, and strengthen your relationship. --- The Dr. Terri Show is presented by Evexias Health Solutions, for more visit: https://www.evexias.com/
Hormone Replacement Therapy has existed long in the 60's before we were even taught of the right dosages for women. In fact, up until the 90's, medical studies mostly excluded women, making medical solutions only in consideration of men. With this in mind, have you ever asked yourself if you've been giving your body the right care especially once you're undergoing perimenopause and menopause?Join us in this episode as Dr. Stephanie Nielsen, one of our in-house clinicians, dive into different research studies with Dr. Betty Murray, Founder of Living Well Dallas, a Functional Medicine Center that provides whole body patient-centric care. Dr. Stephanie and Dr. Betty discuss the context behind hormonal therapies - which you may not even be aware that you have already been taking to manage your body such as birth control pills despite not knowing of potential risks and benefits of each one towards your symptoms.Dr. Stephanie and Dr. Betty also debunk myths, and go into the differences and impact of hormonal replacement therapy and bioidentical hormone replacement therapy. Hormone replacement therapy being synthetic, while bioidentical hormone replacement therapy being more similar to what already exists and what is being produced by the body. Though they may be used for the same purpose, but definitely have different implications on the body. Don't miss out on today's episode to ensure you make the best decisions for your body! Here are some of the concepts that were discussed throughout the episode as well:The Impact of Birth Control PillsDiscussing the Initial Study of the Women's Health InitiativeConsidering Health Stages, Risks, and HabitsThe Differences and Similarities of HRT and BHRTHow Hormones Work and Get ProducedMedications that may screw up your liverProper Ways of Looking Into Research Studies on HealthImportance of Looking Into Your DNADementia and HormonesDiet and Menopause▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Keep yourself up to date on The DNA Talks Podcast! Follow our socials below:The DNA Talks Podcast Instagram https://www.instagram.com/dnatalkspodcast/Dr. Stephanie Nielsen's website https://www.wishinguwellness.com/Dr. Betty Murray's website at https://www.bettymurray.com/You may also watch this episode on YouTube.▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Music: Inspiring Motivational Background by Stock-Waveshttps://www.stock-waves.com/https://protunes.net/Video Link: https://www.youtube.com/watch?v=pbwVDTn-I0o&list=PLQtpqy3zeTGB7V5lkhkfBVaiZyrysv_fG&index=5▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Music: Peaceful Corporate by Stock-Waveshttps://protunes.net/Video Link: https://www.youtube.com/watch?v=I34bTKW8ud0&list=PLQtpqy3zeTGB7V5lkhkfBVaiZyrysv_fG▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Medical Disclaimer: The intention of this podcast is to enhance your lifestyle by changing what is within your control. This does not substitute the medical advice given by your personal doctor, therapist, and other healthcare professionals.
Featuring perspectives from Dr Harold J Burstein, Ms Kelly Fischer, Dr Komal Jhaveri and Ms Melissa Rikal, including the following topics: Introduction (0:00) The Utility of Genomic Assays in Treatment Decision-Making for HR-Positive, HER2-Negative Localized Breast Cancer (10:21) The Role of CDK4/6 Inhibitors in Therapy for HR-Positive Breast Cancer (37:18) Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer (mBC) (1:04:27) Alpelisib and Capivasertib in Treatment for HR-Positive mBC (1:28:40) NCPD information and select publications
Featuring perspectives from Dr Rahul Aggarwal, Dr Adam S Kibel, Dr Laurence Klotz and Dr Sandy Srinivas, moderated by Dr Elisabeth I Heath, including the following topics: Introduction (0:00) Recent Data Defining the Optimal Use of Hormonal Therapy for Nonmetastatic Prostate Cancer — Dr Kibel (2:39) Side Effects and Other Practical Considerations with Hormonal Therapy for Nonmetastatic Prostate Cancer — Dr Klotz (27:04) Current and Future Approaches to Hormonal Therapy for Metastatic Prostate Cancer — Dr Aggarwal (51:07) New Considerations with the Use of PARP Inhibitors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Dr Srinivas (1:13:53) Other Novel Therapies for Patients with Metastatic Prostate Cancer — Dr Heath (1:38:52) CME information and select publications
Featuring perspectives from Dr Andrew J Armstrong and Ms Brenda Martone, including the following topics: Introduction: Overview of Prostate Cancer; Hormonal Therapy (0:00) Radiopharmaceuticals for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) (24:11) Biomarker Testing for mCRPC; PARP Inhibitors for mCRPC (49:33) NCPD information and select publications
Featuring perspectives from Dr Emmanuel S Antonarakis and Dr Rana R McKay, including the following topics. Role of Hormonal Therapy in Prostate Cancer (PC) Management — Dr McKay (0:00) Evidence-Based Use of Other Therapeutic Approaches — Dr Antonarakis (35:15) CME information and select publications
Featuring perspectives from Dr Andrew J Armstrong and Dr Maha Hussain, including the following topics: Introduction: Carpool Karaoke — RTP Style (0:00) Hormonal Therapy (13:36) Other Treatment Approaches (36:50) CME information and select publications
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy and Novel Therapeutic Strategies for Patients with Prostate Cancer — Maha Hussain, MD, FACP, FASCO CME information and select publications
Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Prostate).
HOST - Dawn Marie R. Davis, M.D. GUEST - Jewel M. Kling, M.D., M.P.H. The number of midlife women transitioning into menopause is substantial with more than one million women in the U.S. entering menopause each year. Symptoms such as vasomotor symptoms (VMS), mood and sleep disturbances, and sexual problems are common during the menopause transition, yet often go untreated. Menopausal hormone therapy (HT) is often the preferred and most effective treatment option for menopausal symptoms. Dr. Juliana (Jewel) Kling joins the podcast to discuss this important topic. This episode is brought to you by: https://www.astellas.com/us/ Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Learn more about this episode at: https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition
In this episode, Dr. Rena Malik discusses the complex topic of low sexual desire. She delves into the prevalence of low libido in both men and women, highlighting the various factors that can impact sexual desire, including medications, relationship issues, stress, and psychological disorders. Dr. Malik shares insights on the role of the brain in sexual desire, as well as the potential impact of mindfulness practice, nutrition, sleep, and exercise on improving sexual function. She also explores the use of supplements, medications, and hormone replacement therapy as potential interventions. Join us as we explore the multifaceted nature of sexual desire and the potential strategies for addressing low libido. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments ▶️Chapters: 00:00 - Introduction 02:23 - Understanding the Prevalence of Low Sexual Desire and Its Impact 08:49 - The Role of the Brain in Sexual Desire: Neurological Signal Pathways 13:20 - Medications and Their Influence on Sexual Desire 18:45 - Relationship Issues, Stress, and Psychological Factors in Low Sexual Desire 24:10 - The Impact of Mindfulness Practice on Body Image and Sexual Satisfaction 29:57 - Nutritional and Lifestyle Factors Affecting Sexual Desire 34:18 - Scheduling Intimacy and its Role in Awakening Desire 39:02 - Communicating with Your Partner for a Fulfilling Sex Life 43:50 - Medical Solutions for Low Libido: Medications, Hormonal Therapy, and Supplements 48:15 - Conclusion Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices
Featuring perspectives from Dr Stephanie L Graff and Dr Erica Mayer, including the following topics: Introduction: Endocrinology and Pharmacology of Hormonal Therapy for Breast Cancer (0:00) Current and Emerging Strategies for Localized Hormone Receptor (HR)-Positive Breast Cancer — Dr Graff (17:02) Advances in the Care of Patients with HR-Positive Metastatic Breast Cancer — Dr Mayer (38:59) CME information and select publications
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Brian Slomovitz to discuss hormonal therapy in advanced or recurrent endometrial cancer. Dr. Slomovitz is a Gynecologic Oncologist at Mount Sinai Medical Center in Miami Beach, Florida, and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specifically in immunotherapy and novel biomarker therapeutics. He also is a leader in sentinel lymph node detection for gynecologic malignancies. Highlights: While current recommendations include chemotherapy as first-line treatment for metastatic or recurrent endometrial cancer, emerging evidence suggests that hormonal therapy, particularly in combination with other treatment regimens guided by biomarkers, could be efficacious in selected subtypes (low-grade endometrioid carcinoma of the endometrium). Hormonal therapy offers many benefits, including oral dosing and fewer side effects. If there is progression after hormonal therapy, patients would still be eligible for other trials, and use of hormonal therapy does not preclude the use or limit the benefits of future chemotherapy.
Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Harold Burstein, Dr Asher Chanan-Khan, Dr Komal Jhaveri, Dr Brad S Kahl, Dr Alicia K Morgans, Dr Philip A Philip, Dr Gregory J Riely, Dr Matthew R Smith and Dr Heather Wakelee, including the following topics: Introduction (0:00) Role of Hormonal Therapy in Prostate Cancer Management — Dr Smith (1:50) Clinical Questions and Cases (13:18) Evidence-Based Use of Other Therapeutic Approaches in Metastatic Castration-Resistant Prostate Cancer — Dr Morgans (26:08) Clinical Questions and Cases (38:01) CME information and select publications
Hormonal therapy can cause a number of troubling issues for women, including loss of libido, hot flashes, and pain during sex. At the 2023 American Society of Clinical Oncology Annual Meeting, Dr. Kristin Rojas chaired a session called “A Juggling Act: Managing the Toxicity of Estrogen Deprivation for Patients With Breast Cancer.” Listen to the podcast to hear Dr. Rojas explain: some of the most problematic issues and how they can be treated some of the therapies, products, and devices to avoid how women can find help for sexual issues
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer — Faculty Presentation 1: Optimizing the Use of Hormonal Therapy in Prostate Cancer Management — Tanya B Dorff, MD CME information and select publications
Turns out we have a lot of listeners who know things about rye grass, and another who had a spontaneous one-week romantic liason that started with an empty stomach.
Doctors are looking for new treatment options for people diagnosed with metastatic hormone receptor-positive, HER2-negative breast cancer that has grown during treatment with hormonal therapy and a CDK4/6 inhibitor. Dr. Virginia Kaklamani is part of the team investigating elacestrant, an oral medicine, to see if offers more benefits than Faslodex (chemical name: fulvestrant), which is the current standard of care. Listen to the podcast to hear Dr. Kaklamani explain: the type of medicine elacestrant is and how it works why it's important that elacestrant showed benefits for breast cancers with an ESR1 mutation when we might hear if elacestrant is approved by the U.S. Food and Drug Administration (FDA)
Featuring perspectives from Prof Karim Fizazi and Prof Stéphane Oudard, including the following topics: Introduction: Journal Club — Karim Fizazi, MD, PhD and Stéphane Oudard, MD, PhD (0:00) Case: A man in his late 50s with Gleason 7 prostate cancer after prostatectomy/radiation therapy/androgen deprivation therapy (ADT) experiences biochemical recurrence 2 years later (PSA 0.5; doubling time 9 months) — Philip L Brooks, MD (10:58) Case: A man in his early 70s with a pacemaker presents with de novo metastatic hormone-sensitive prostate cancer (mHSPC) after cerebrovascular accident — Nasfat Shehadeh, MD (28:50) Case: A man in his late 40s with multiple medical comorbidities presents with de novo mHSPC (PSA 19.4) and responds to ADT/docetaxel — Gurveen Kaur, MD (47:00) Case: A man in his mid 60s with de novo mHSPC receives leuprolide, and PSA levels decrease from 865 ng/mL to 1.34 ng/mL — Joanna Metzner-Sadurski, MD (50:38) Case: A man in his late 50s with mHSPC receives leuprolide, experiences disease progression 1.5 years later and responds to abiraterone/prednisone but on liquid biopsy is found to have an AR T878 mutation — Niyati A Nathwani, MD (54:30) Case: A man in his mid 60s presents with de novo metastatic prostate cancer and experiences disease progression on ADT + docetaxel, now with progressive disease on abiraterone/prednisone; germline CHEK2 mutation — Syed F Zafar, MD (56:51) CME information and select publications
Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Prof Karim Fizazi and Prof Stéphane Oudard, moderated by Dr Neil Love.
Going through chemo and cancer treatment, you probably thought you were done with cancer once you run the bell. Wrong. Bring on Tamoxifen therapy for 5 years, 10 years, or even indefinitely can mean you feel like a stranger in your body. But here is the good news - there are steps you can take to get rid of these side effects. For those on tamoxifen, you will want to listen to this episode because we are diving into the side effects of the drug and what you can do to be free from those side effects.
Featuring perspectives from Dr Matthew Smith, including the following topics: Introduction: Abemaciclib for Prostate Cancer? (0:00) Case: A man in his early 70s with a PSA of 150 ng/mL, Gleason 4 + 4 and upper abdominal adenopathy — Jennifer L Dallas, MD (9:30) Case: A man in his late 60s with Gleason 4 + 4, PSA of 147 ng/mL and a negative CT — David S Morris, MD (34:30) Case: A man in his late 60s with coronary artery disease and Gleason 4 + 4 who underwent external beam radiation therapy (EBRT) in 2013 and now has increasing PSA of 3.8 with a 6-month doubling time — Gurveen Kaur, MD (37:56) Case: A man in his mid 60s who experiences M0 progression after EBRT followed by androgen deprivation therapy (ADT) but refuses to continue ADT — Henna Malik, MD (41:44) Case: A man in his early 50s with a slowly rising PSA (now 1.31) after radical prostatectomy and salvage radiation therapy; PSMA PET scan denied by insurance, now appealed — Kapisthalam (KS) Kumar, MD (50:23) Case: A man in his late 70s with Gleason 5 + 4 and a PSA of 23 ng/mL increasing after EBRT followed by ADT, cryoablation and enzalutamide; after a response, 18F-fluciclovine PET shows subtle focus of uptake in left prostate — Susmitha Apuri, MD (57:06) CME information and select publications
© 2020-2026 Ivy Podcast Discovery LLC
